Advanced search
Publication Cover
Journal of Asthma Volume 59, 2022 - Issue 12
Submit an article Journal homepage
317
Views
1
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Asthma biologic trial eligibility and real-world outcomes in the United States

Regina W. Lam,a Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USAView further author information
, BA,
Jonathan W. Inselman,b Division of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USAView further author information
, MS,
Molly M. Jeffery,b Division of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USAView further author information
, PhD,
Jacob T. Maddux,c Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, AZ, USAView further author information
, MD,
Nilay D. Shah,b Division of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA;d OptumLabs, Cambridge, MA, USAView further author information
, PhD &
Matthew A. Rank,c Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, AZ, USA;e Division of Pulmonology, Phoenix Children’s Hospital, Phoenix, AZ, USACorrespondence[email protected]
View further author information
, MD
Pages 2352-2359 | Received 11 Jul 2021, Accepted 21 Nov 2021, Published online: 06 Dec 2021

References

  • Food and Drug Administration. Asthma Surveillance Data; 2019 [accessed 2019 Mar]. www.cdc.gov/asthma/asthmadata.htm.
  • Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3(1):1.
  • Inselman JW, Jeffery MM, Maddux JT, Shah ND, Rank MA. Trends and disparities in asthma biologic use in the United States. J Allergy Clin Immunol Pract. 2020;8(2):549–554.
  • McCracken JL, Tripple JW, Calhoun WJ. Biologic therapy in the management of asthma. Curr Opin Allergy Clin Immunol. 2016;16(4):375–382. doi:10.1097/ACI.0000000000000284.
  • Chung KF. Diagnosis and management of severe asthma. Semin Respir Crit Care Med. 2018;39(1):91–99. doi:10.1055/s-0037-1607391.
  • Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials. 2015;16(495):495.
  • Albers FC, Müllerová H, Gunsoy NB, Shin J-Y, Nelsen LM, Bradford ES, Cockle SM, Suruki RY. Biologic treatment eligibility for real-world patients with severe asthma: the IDEAL study. J Asthma. 2018;55(2):152–160. doi:10.1080/02770903.2017.1322611.
  • Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?. Thorax. 2007;62(3):219–223. doi:10.1136/thx.2006.066837.
  • Pahus L, Alagha K, Sofalvi T, Vachier I, Bourdin A, Molinari N, Chanez P, COBRA Consortium. External validity of randomized controlled trials in severe asthma. Am J Respir Crit Care Med. 2015;192(2):259–261.
  • Brown T, Jones T, Gove K, Barber C, Elliott S, Chauhan A, et al. Randomised controlled trials in severe asthma: selection by phenotype or stereotype. Eur Respir J. 2018;52(6):1801444.
  • Akenroye A, Keet C. Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma. J Allergy Clin Immunol Pract. 2020;8(2):739–741.
  • Briasoulis O, Breckenridge R, Nunn A. External Validity of Trials Should Be Taken into Account before Asthma Drug Candidates Reach Market Authorisation. Lancet Respir Med. 2016; 4(8):601–603. doi:10.1016/S2213-2600(16)30118-7.
  • Krause JH, Saver RS. Real-world evidence in the real world: beyond the FDA. Am J Law Med. 2018;44(2–3):161–179.
  • Food and Drug Administration. FDA Announces 4 Grant Awards for Projects Exploring the Use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making; 2020 [accessed 2020 Nov 30]. www.fda.gov/drugs/science-and-research-drugs/fda-announces-4-grant-awards-projects-exploring-use-real-world-data-generate-real-world-evidence.
  • Wallace PJ, Shah ND, Dennen T, Bleicher PA, Bleicher PD, Crown WH. Optum labs: building a novel node in the learning health care system. Health Aff (Millwood). 2014;33(7):1187–1194.
  • Maddux JT, Inselman JW, Jeffery MM, Lam RW, Shah ND, Rank MA. Adherence to asthma biologics: implications for patient selection, step therapy, and outcomes. Chest. 2021;159(3):924–932. doi:10.1016/j.chest.2020.10.050.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.